Delivery Order SPE2DB22D2206-SPE2DB24FFF05

Award Date 1/23/24
Potential Completion Date 1/24/24
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ADRENALIN 30 MG/30 ML VIAL 30ML. The Firm Fixed Price contract, valued at $1,364.48, has an ultimate completion date of November 7, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award, valued at $1,010.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of "ADRENALIN 1 MG/ML VIAL" and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $1,085.50 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the drug Adrenalin 30 mg/30 ml vial. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $5,445.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order contract for the pharmaceutical product "Adrenalin 1 mg/ml vial" with a completion date of May 3, 2024. The contract type is Firm Fixed Price, and there was no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,302.60 delivery order contract is for the supply of 4565468588 - ADRENALIN 30 MG/30 ML VIAL 30ML, a pharmaceutical product. The contract has an ultimate completion date of August 16, 2024 and uses a Firm Fixed Price pricing type. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts...
This federal contract award, valued at $1,123.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of ADRENALIN 30 MG/30 ML VIAL 30ML, a critical pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order worth $13,676.07, is for the supply of the pharmaceutical product ADRENALIN 30 MG/30 ML VIAL 30ML. The contract has a period of performance through March 12, 2025 and is a firm fixed-price contract type. Amerisourcebergen Drug Corp is a for-profit organization and has an active registration in...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $2,122.43 to supply the U.S. Defense Logistics Agency (DLA) with the pharmaceutical product "ADRENALIN 30 MG/30 ML VIAL 30ML". The contract has a completion date of July 16, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
This federal contract award is for the delivery of Adrenalin 1 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,611.12, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm fixed-price delivery order with a completion date of February 1, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide ADRENALIN 30 MG/30 ML VIAL 30ML, a pharmaceutical product, with a potential value of $1,302.60. This award does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to deliver a comprehensive range of medications and...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FFF05
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ADRENALIN 30 MG/30 ML VIAL 30ML, a pharmaceutical product. The contract has a ceiling value of $2,197.71 and a period of performance ending on January 24, 2024.

Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/13/25, 10:03 AM